NorthCrest Asset Manangement’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
LMFP
SI
GGI
QCM
MIM
DLA
MGIA
ERP
CCM
NorthCrest Asset Manangement's NVS Position: Q2 2026 in Review
NorthCrest Asset Manangement reduced its Novartis (NVS) stake by 2.4% in Q2 2026, selling an estimated $48.6K and leaving 12,983 shares worth $2.01M. The position accounts for 0.05% of the portfolio, ranked #246.
NorthCrest Asset Manangement first reported a position in NVS in Q4 2021 and has held it in 18 quarters since. The position peaked at $6.62M in Q3 2024. 285 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- NorthCrest Asset Manangement held 12,983 shares of Novartis worth $2.01M as of Q2 2026.
- NorthCrest Asset Manangement sold 324 Novartis shares in Q2 2026, an estimated $48.6K.
- Novartis made up 0.05% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #246 holding.
- NorthCrest Asset Manangement first reported a position in Novartis in Q4 2021 and has held it in 18 quarters since.
- NorthCrest Asset Manangement's Novartis position peaked at $6.62M in Q3 2024.
- 285 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.